Ternary Therapeutics

Molecular glues, engineered from the surface up

London, United Kingdom · Founded 2024 · $4.4M raised

Headquarters
London
Employees
1–10
Founded
2024
Business Model
B2B
Total Funding
$4.4M
Last Round
$4.4M SeedMar 2026
Rounds
1

About

Ternary Therapeutics (TernaryTx) is a London-based biotech company founded in 2024 that uses frontier AI and deep physics to design molecular glue therapeutics — small molecules that work by glueing two proteins together. Its proprietary four-engine computational platform (Leopard, Puffin, Gecko, Octopus) combines machine learning, physics-based molecular modelling, and rapid laboratory testing to turn molecular glue drug discovery from a chance-based process into a repeatable engineering system. The company has a pipeline of preclinical programmes in inflammatory and neuroinflammatory diseases and raised a €4.1 million seed round in March 2026 led by daphni.

Summary

Ternary Therapeutics is a Biotech company based in London, United Kingdom, founded in 2024. It has raised $4.4M in total across 1 round, most recently a $4.4M Seed round in Mar 2026. Investors include Daphni, Pace Ventures and UK Innovation & Science Seed Fund.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundMar 2026
$4.4M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ternary Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/ternary-therapeutics"><img src="https://indexed.vc/api/badge/company/ternary-therapeutics" alt="Ternary Therapeutics on Indexed.vc" width="260" height="76" /></a>